| Package | Per pill | Total price | Save | Order |
|---|---|---|---|---|
| 10mg × 30 Pills | $2.14 | $64.08 + Bonus - 4 Pills | - | Add to cart |
| 10mg × 60 Pills | $1.93 | $116.07 + Bonus - 4 Pills | $12.60 | Add to cart |
| 10mg × 90 Pills | $1.87 | $168.08 + Bonus - 7 Pills | $24.30 | Add to cart |
| 10mg × 120 Pills | $1.75 | $210.02 + Bonus - 7 Pills Free Trackable Delivery | $46.80 | Add to cart |
| 10mg × 180 Pills | $1.69 | $304.20 + Bonus - 11 Pills Free Trackable Delivery | $81.00 | Add to cart |
| 10mg × 360 Pills | $1.50 | $540.87 + Bonus - 11 Pills Free Trackable Delivery | $230.40 | Add to cart |
Prasugrel 10 mg: Your Key to Reduced Cardiac Risks
Cardiovascular diseases remain one of the world's leading causes of deaths and illnesses. Heart attacks, strokes, and other cardiac complications arise from blood clots forming in damaged blood vessels. Anticoagulant medications help prevent these clots from developing. Prasugrel, a type of anticoagulant, is widely used for this purpose. In this article, we shall delve into the workings, benefits, and side effects of prasugrel 10 mg.
What is Prasugrel 10 mg? Prasugrel is an antiplatelet medicine that inhibits the P2Y12 platelet receptor. This receptor triggers platelet activation when bound by adenosine diphosphate (ADP). By blocking this receptor, prasugrel stops platelets from clumping together and forming clots. It is used in combination with low-dose aspirin to treat patients with acute coronary syndrome (ACS) who are to be managed with percutaneous coronary intervention (PCI).
Prasugrel 10 mg tablets contain 10.5 mg prasugrel hydrochloride equivalent to 10 mg prasugrel and are designed to be taken once a day. The 10 mg dose is recommended for most patients. However, doses may be adjusted based on body weight for patients under 60 kg.
How Does Prasugrel 10 mg Work? Prasugrel irreversibly binds to the P2Y12 receptor on platelet surfaces. This receptor normally binds ADP released from damaged blood vessels. The binding of ADP to P2Y12 activates platelets, causing them to clump together and form thrombi. Prasugrel occupies these receptors, thus preventing platelet activation by ADP. As a result, it inhibits the formation of platelet thrombi in damaged coronary arteries.
Prasugrel is more potent than clopidogrel, another widely used antiplatelet medicine. It binds to P2Y12 receptors faster and to a greater extent than clopidogrel, resulting in quicker and more complete platelet inhibition. This is important in ACS patients who require fast and effective antiplatelet action to prevent cardiac events.
Benefits of Prasugrel 10 mg Using prasugrel 10 mg daily in combination with aspirin provides several benefits to patients with ACS undergoing PCI:
Contraindications and Precautions Prasugrel 10 mg is contraindicated in:
Prasugrel should be used with caution in:
Side Effects of Prasugrel 10 mg The most common side effects of prasugrel 10 mg are:
Serious side effects that require immediate medical attention include:
Dosage and Administration The recommended dose of prasugrel is 10 mg taken orally once daily. A 60 mg loading dose should be given as soon as possible after diagnosis of ACS and at least 1 to 24 hours prior to PCI. The patient should continue taking 10 mg daily for at least 12 months unless the doctor advises otherwise.
Prasugrel 10 mg tablets should be swallowed whole with a glass of water. The tablets can be taken with or without food. Patients who are unable to swallow tablets whole can crush the tablets, mix with 50 mL of water, stir well, and administer immediately. The crushed tablets should not be stored for future use.
Cost of Prasugrel 10 mg The cost of prasugrel 10 mg varies depending on the country, pharmacy, and insurance coverage. In the United States, a 30-day supply of brand-name prasugrel (Effient) can cost around $400. Generic versions may be more affordable, with a 30-day supply costing around $100.
In the UK, a 28-day supply of prasugrel 10 mg tablets costs around £40 for the brand-name version and around £20 for generic versions.
In Canada, a 30-day supply of prasugrel 10 mg costs around CAD 150 for brand-name and CAD 70 for generic versions.
Insurance coverage and patient assistance programs may help reduce the out-of-pocket costs of prasugrel.
Buy Prasugrel 10 mg Online Prasugrel 10 mg can be purchased online from licensed pharmacies with a valid prescription. Some online pharmacies offer discounts, especially for bulk purchases. However, it's important to ensure the authenticity and safety of the medication.
When buying prasugrel online:
Conclusion Prasugrel 10 mg is an effective antiplatelet medication for reducing the risk of cardiovascular events in ACS patients undergoing PCI. It works by irreversibly blocking the P2Y12 receptor on platelet surfaces, preventing platelet activation and thrombus formation.
While generally well-tolerated, prasugrel 10 mg carries a risk of bleeding, especially in patients with active bleeding, recent trauma or surgery, bleeding disorders, and those 75 years or older. Patients should carefully weigh the benefits against the risks and discuss any concerns with their doctor.
The cost of prasugrel 10 mg can be high, but generic versions and patient assistance programs may provide more affordable options. Buying online can also help reduce costs, but patients must ensure they use only licensed and reputable online pharmacies.
By understanding how prasugrel works, its benefits and risks, and how to obtain it safely, patients can make informed decisions about their cardiovascular health.
Tables: Table 1: Prasugrel vs Clopidogrel
| Characteristic | Prasugrel | Clopidogrel |
|---|---|---|
| Mechanism of Action | Irreversible P2Y12 inhibition | Reversible P2Y12 inhibition |
| Onset of Action | Faster (within 30 minutes) | Slower (several hours) |
| Platelet Inhibition | Greater (80% by 1 hour) | Lower (40-60% by 2 hours) |
| Dose | 10 mg daily | 75 mg daily |
| Approved Indications | ACS with PCI | ACS, recent MI, recent stroke, peripheral artery disease |
| Contraindications | Active bleeding, history of TIA/stroke, severe liver impairment | Active bleeding |
| Common Side Effects | Bleeding, hypersensitivity reactions | Bleeding, hypersensitivity reactions, diarrhea |
Table 2: Cost Comparison of Prasugrel 10 mg Across Countries
| Country | 30-day Supply of Brand-name | 30-day Supply of Generic |
|---|---|---|
| USA | $400 | $100 |
| UK | £40 | £20 |
| Canada | CAD 150 | CAD 70 |
Table 3: Tips for Buying Prasugrel 10 mg Online
| Tip | Description |
|---|---|
| 1 | Only use licensed and reputable online pharmacies |
| 2 | Always have a valid prescription from a doctor |
| 3 | Check the authenticity of the medication and the pharmacy's physical address |
| 4 | Be wary of very low prices or pharmacies that dispense medication without a prescription |
| 5 | Monitor your credit card statements for unauthorized charges |
Lists: List 1: Contraindications and Precautions of Prasugrel 10 mg
• Active bleeding (e.g. intracranial hemorrhage) • History of transient ischemic attack (TIA) or stroke • Severe hepatic impairment • Concomitant use of warfarin or other anticoagulants • Bleeding disorders (e.g. thrombocytopenia) • Recent trauma or surgery • Moderate hepatic impairment • Renal impairment • Patients 75 years of age or older • Body weight less than 60 kg
List 2: Common Side Effects of Prasugrel 10 mg
• Bleeding (e.g. bruising, petechiae, epistaxis, gastrointestinal bleeding)
• Hypersensitivity reactions (e.g. rash, angioedema) • Thrombotic thrombocytopenic purpura (TTP) • Increased risk of bleeding in patients with active bleeding or at high risk of bleeding • Increased risk of bleeding in patients with recent trauma or surgery • Increased risk of bleeding in patients with bleeding disorders
List 3: Serious Side Effects of Prasugrel 10 mg
• Signs of bleeding (e.g. vomiting blood, black or bloody stools, coughing up blood) • Signs of TTP (e.g. purpura, bruising, decreased platelet count, hemolytic anemia)
• Signs of allergic reaction (e.g. difficulty breathing, swelling of the face, lips, tongue, or throat)
Thrombotic Complications in Patients with Acute Coronary Syndrome (ACS): An Overview
Introduction Acute coronary syndrome (ACS) is a spectrum of acute cardiovascular disorders that include unstable angina, non-ST-elevation myocardial infarction (NSTEMI), and ST-elevation myocardial infarction (STEMI). Thrombotic complications are a major concern in patients with ACS, as they can lead to further damage to the heart muscle and increase the risk of mortality. In this article, we will discuss the incidence, risk factors, clinical presentation, diagnosis, treatment options, and prevention strategies for thrombotic complications in patients with ACS.
Incidence and Risk Factors The incidence of thrombotic complications in patients with ACS varies depending on the severity of the condition and the presence of risk factors. According to a study published in the Journal of the American College of Cardiology, the incidence of in-hospital thrombotic complications in patients with ACS is approximately 5-10% (1).
Several risk factors contribute to the development of thrombotic complications in patients with ACS. These include:
Clinical Presentation Thrombotic complications in patients with ACS may present with various clinical manifestations. These include:
Diagnosis The diagnosis of thrombotic complications in patients with ACS is based on a combination of clinical presentation, electrocardiographic findings, and biochemical markers. The following diagnostic tests are commonly used:
Treatment Options The treatment of thrombotic complications in patients with ACS involves a combination of pharmacological and interventional therapies. The primary goals of treatment are to prevent further thrombosis, reduce ischemia, and improve patient outcomes.
Prevention Strategies Prevention of thrombotic complications is crucial in patients with ACS. The following strategies can help reduce the risk of thrombotic events:
Frequently Asked Questions (FAQs)
Q: What are the most common thrombotic complications in ACS? A: The most common thrombotic complications in ACS are recurrent myocardial infarction, stent thrombosis, and stroke.
Q: How does diabetes increase the risk of thrombotic complications in ACS? A: Diabetes increases the risk of thrombotic complications in ACS by promoting endothelial dysfunction, hypercoagulability, and platelet activation.
Q: What is the role of novel oral anticoagulants (NOACs) in preventing thrombotic complications in ACS? A: NOACs, such as apixaban and rivaroxaban, have been shown to reduce the risk of stroke and systemic embolism in patients with ACS, particularly those with atrial fibrillation.
Q: How long should dual antiplatelet therapy (DAPT) be continued in patients with ACS? A: The duration of DAPT in patients with ACS depends on the type of ACS and the presence of high-risk features. The general recommendation is to continue DAPT for at least 12 months after PCI with a drug-eluting stent.
Table 1: Risk Factors for Thrombotic Complications in ACS
Risk Factors
Table 2: Treatment Options for Thrombotic Complications in ACS
Treatment Options
In conclusion, thrombotic complications are a significant concern in patients with ACS, and their prevention and management are crucial for improving patient outcomes. By understanding the incidence, risk factors, clinical presentation, diagnosis, treatment options, and prevention strategies for thrombotic complications in ACS, healthcare providers can provide optimal care and reduce the risk of adverse events in these patients. Ongoing research into novel therapies and personalized approaches may further improve the management of thrombotic complications in ACS.
References: